Patents Assigned to TSH BIOPHARM CORPORATION LTD.
  • Patent number: 9744165
    Abstract: Dextromethorphan is used to lower blood pressure in a subject suffering from hypertension, alone or in combination with another anti-hypertensive agent. In particular, dextromethorphan acts synergistically with a calcium channel blocker, such as amlodipine, to result in a major improvement in the treatment of hypertension, with no or little adverse effects.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: August 29, 2017
    Assignee: TSH Biopharm Corporation Ltd.
    Inventors: Jaw-Wen Chen, Hsi-Chieh Wang, Shin-Yi Juang
  • Patent number: 8883207
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: November 11, 2014
    Assignees: TSH Biopharm Corporation Ltd., Innopharmax, Inc.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu
  • Publication number: 20130053411
    Abstract: Dextromethorphan is used to lower blood pressure in a subject suffering from hypertension, alone or in combination with another anti-hypertensive agent. In particular, dextromethorphan acts synergistically with a calcium channel blocker, such as amlodipine, to result in a major improvement in the treatment of hypertension, with no or little adverse effects.
    Type: Application
    Filed: April 29, 2011
    Publication date: February 28, 2013
    Applicant: TSH BIOPHARM CORPORATION LTD.
    Inventors: Jaw-Wen Chen, His-Chieh Wang, Shin-Yi Juang
  • Publication number: 20120245212
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Application
    Filed: September 29, 2010
    Publication date: September 27, 2012
    Applicants: INNOPHARMAX, INC., TSH BIOPHARM CORPORATION LTD.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu